Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL

Bone Marrow Transplant. 2022 Oct;57(10):1612-1614. doi: 10.1038/s41409-022-01766-8. Epub 2022 Jul 25.

Authors

Jiexian Ma^#¹, Shunrong Sun^#², Yingwei Hu^#², Min Wu², Lin Shen², Wulipan Fulati², Zilan Huang², Wensi Qian², Pingping Chen², Mingyue Chen², Yanhui Xie³

Affiliations

¹ Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China. jiexianma@hotmail.com.
² Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
³ Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China. yanhuixie@163.com.

^# Contributed equally.

PMID: 35879604
DOI: 10.1038/s41409-022-01766-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, Large B-Cell, Diffuse* / therapy
Stem Cell Transplantation
Transplantation Conditioning
Transplantation, Autologous